Horizon Discovery appoints Dr Susan Galbraith and Susan Searle as Non-Executive Directors
Dr Galbraith is Senior Vice President and Head of Oncology Innovative Medicines at AstraZeneca, and Susan Searle is co-founder and ex-CEO of Imperial Innovations Group. Both join Horizon with immediate effect.
